Skip to main content
Saumya Das, MD, Cardiology, Boston, MA

SaumyaDasMD

Cardiology Boston, MA

Cardiac Electrophysiology, Cardiovascular Disease Genetics

Professor, Harvard Medical School, MGH

Dr. Das is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Das' full profile

Already have an account?

  • Office

    55 Fruit Street Grb 804
    Massachusetts General Hospital
    Boston, MA 02114
    Phone+1 617-724-0058
    Fax+1 617-724-2058

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 2004 - 2005
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2002
  • Harvard Medical School
    Harvard Medical SchoolClass of 2000

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2002 - 2025
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Clinical Cardiac Electrophysiology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Proteomic Signature a Key to Early Detection of Fatty Liver Disease: Study
    Proteomic Signature a Key to Early Detection of Fatty Liver Disease: StudyDecember 19th, 2024
  • Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions
    Heart Failure Strategically Focused Research Network: Summary of Results and Future DirectionsSeptember 8th, 2022
  • LQT Therapeutics Announces up to C$1.8M in Seed Funding Led by Fonds De Solidarité FTQ to Accelerate Research of New Therapies for Long QT Syndrome
    LQT Therapeutics Announces up to C$1.8M in Seed Funding Led by Fonds De Solidarité FTQ to Accelerate Research of New Therapies for Long QT SyndromeJanuary 8th, 2020